CAMELLIA Adds To Belviq’s CV Confidence But ‘Caution’ Still Needed

 
• By Ian Haydock
  
Obesity
WEIGHT LOSS BENEFITS AND CV SAFETY CONFIRMED FOR BELVIQ, BUT OTHER QUESTIONS LINGER • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D